Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: FASEB J. 2020 Jun 16;34(8):10560–10573. doi: 10.1096/fj.202000495RR

Figure 7. Summary of HFpEF model presenting splenocardiac and cardiorenal inflammation in obesity-prone ALX-deficient mice.

Figure 7.

Obesity prone ALX null mice develops HFpEF phenotypes with leukocyte-directed suboptimal inflammation and dysregulation of energy dynamics with endothelial dysfunction.